Physician Data Query

Last uploaded: January 31, 2024
Preferred Name

liraglutide

Synonyms

N26-(hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide

Definitions

A long-acting, fatty acylated glucagon-like peptide-1 (GLP-1) analog administered subcutaneously, with antihyperglycemic activity. Liraglutide's prolonged action and half-life of 11-15 hours are attributed to the attachment of the fatty acid palmitic acid to GLP-1 that reversibly binds to albumin. Albumin binding protects liraglutide from immediate degradation and elimination and causes GLP-1 to be released from abumin in a slow and consistent manner. This agent may cause thyroid C-cell tumors and increases the risk of acute pancreatitis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C82239" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C82239" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000792738

altLabel

N26-(hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide

Victoza

NN2211

CAS Registry

204656-20-2

cui

C1456408

C1099192

C2732208

DATE FIRST PUBLISHED

2018-03-27

Date last modified

2018-05-01

definition

A long-acting, fatty acylated glucagon-like peptide-1 (GLP-1) analog administered subcutaneously, with antihyperglycemic activity. Liraglutide's prolonged action and half-life of 11-15 hours are attributed to the attachment of the fatty acid palmitic acid to GLP-1 that reversibly binds to albumin. Albumin binding protects liraglutide from immediate degradation and elimination and causes GLP-1 to be released from abumin in a slow and consistent manner. This agent may cause thyroid C-cell tumors and increases the risk of acute pancreatitis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C82239" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C82239" NCI Thesaurus)

LT

TRD

NCI ID

C82239

notation

CDR0000792738

ORIG STY

Drug/agent

prefLabel

liraglutide

tui

T125

T116

T121

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.bioontology.org/ontology/VANDF/4029703 VANDF CUI
http://purl.bioontology.org/ontology/MESH/D000069450 MESH CUI
http://purl.bioontology.org/ontology/MESH/D000069450 MESH CUI
http://purl.bioontology.org/ontology/NDFRT/N0000191949 NDFRT CUI
http://purl.bioontology.org/ontology/ATC/A10BJ02 ATC CUI
http://purl.bioontology.org/ontology/SCTSPA/444828003 SCTSPA CUI
http://purl.bioontology.org/ontology/MESH/D000069450 MESH CUI
http://purl.bioontology.org/ontology/SCTSPA/444907006 SCTSPA CUI
http://purl.bioontology.org/ontology/SNOMEDCT/444907006 SNOMEDCT CUI
http://purl.bioontology.org/ontology/RXNORM/475968 RXNORM CUI
http://purl.bioontology.org/ontology/SNOMEDCT/444828003 SNOMEDCT CUI
http://purl.bioontology.org/ontology/NDDF/010773 NDDF CUI
http://purl.bioontology.org/ontology/NDFRT/N0000180627 NDFRT CUI
http://purl.bioontology.org/ontology/MSHFRE/D000069450 MSHFRE CUI
http://purl.bioontology.org/ontology/MSHFRE/D000069450 MSHFRE CUI
http://purl.bioontology.org/ontology/RXNORM/897123 RXNORM CUI
http://purl.obolibrary.org/obo/XCO_0000907 XCO LOOM
http://purl.obolibrary.org/obo/CHEBI_71193 CHEBI LOOM
http://scai.fraunhofer.de/AlzheimerOntology#liraglutide ADO LOOM
http://purl.bioontology.org/ontology/VANDF/4029703 VANDF LOOM
http://purl.jp/bio/4/id/201006078991307229 IOBC LOOM
http://mimi.case.edu/ontologies/2009/9/DrugOntology#liraglutide SDO LOOM
http://purl.obolibrary.org/obo/CHEBI_71193 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_71193 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_71193 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_71193 DRON LOOM
http://purl.bioontology.org/ontology/ATC/A10BJ02 ATC LOOM
http://www.semanticweb.org/administrator/ontologies/2022/0/untitled-ontology-34#OWLClassff8da8d5_9699_4253_9f02_2b88b5f0831f WWECA LOOM
http://www.phoc.org.cn/pmo/class/PMO_00019049 PMAPP-PMO LOOM
http://purl.obolibrary.org/obo/NCIT_C82239 BERO LOOM
http://purl.bioontology.org/ontology/MESH/D000069450 MESH LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C439759 RH-MESH LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C82239 NCIT LOOM
https://go.drugbank.com/drugs/DB06655 MDM LOOM
http://www.drugbank.ca/drugs/DB06655 FTC LOOM
http://purl.bioontology.org/ontology/RXNORM/475968 RXNORM LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/444828003 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/NDDF/010773 NDDF LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000180627 NDFRT LOOM
https://bioportal.bioontology.org/ontologies/DMTO.owl#DMTO_0001545 MIDO LOOM
http://purl.obolibrary.org/obo/OMIT_0001438 OMIT LOOM
http://purl.obolibrary.org/obo/MESH_D000069450 BERO LOOM